NL6900235A - - Google Patents
Info
- Publication number
- NL6900235A NL6900235A NL6900235A NL6900235A NL6900235A NL 6900235 A NL6900235 A NL 6900235A NL 6900235 A NL6900235 A NL 6900235A NL 6900235 A NL6900235 A NL 6900235A NL 6900235 A NL6900235 A NL 6900235A
- Authority
- NL
- Netherlands
- Prior art keywords
- acetonide
- contain
- acid
- psoriasis
- flumethasone
- Prior art date
Links
- 239000002253 acid Substances 0.000 abstract 3
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- IPWOSICBVUXMML-UHFFFAOYSA-N (8,9-diacetyloxyanthracen-1-yl) acetate Chemical compound C1=CC(OC(C)=O)=C2C(OC(C)=O)=C3C(OC(=O)C)=CC=CC3=CC2=C1 IPWOSICBVUXMML-UHFFFAOYSA-N 0.000 abstract 1
- MEZCUMCMVYZPAH-UHFFFAOYSA-N 6-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound O=C1CCC2(C)C3C(O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CC(F)C2=C1 MEZCUMCMVYZPAH-UHFFFAOYSA-N 0.000 abstract 1
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 abstract 1
- 229940124091 Keratolytic Drugs 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- YUTJCNNFTOIOGT-UHFFFAOYSA-N anthracene-1,8,9-triol Chemical compound C1=CC(O)=C2C(O)=C3C(O)=CC=CC3=CC2=C1 YUTJCNNFTOIOGT-UHFFFAOYSA-N 0.000 abstract 1
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000001857 anti-mycotic effect Effects 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000002543 antimycotic Substances 0.000 abstract 1
- 229940030999 antipsoriatics Drugs 0.000 abstract 1
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract 1
- 229960002537 betamethasone Drugs 0.000 abstract 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 229960003957 dexamethasone Drugs 0.000 abstract 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 abstract 1
- 229960002311 dithranol Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229960003469 flumetasone Drugs 0.000 abstract 1
- WXURHACBFYSXBI-GQKYHHCASA-N flumethasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O WXURHACBFYSXBI-GQKYHHCASA-N 0.000 abstract 1
- 229940042902 flumethasone pivalate Drugs 0.000 abstract 1
- JWRMHDSINXPDHB-OJAGFMMFSA-N flumethasone pivalate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)COC(=O)C(C)(C)C)(O)[C@@]2(C)C[C@@H]1O JWRMHDSINXPDHB-OJAGFMMFSA-N 0.000 abstract 1
- 229960001347 fluocinolone acetonide Drugs 0.000 abstract 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 abstract 1
- 229960003973 fluocortolone Drugs 0.000 abstract 1
- GAKMQHDJQHZUTJ-ULHLPKEOSA-N fluocortolone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)CO)[C@@]2(C)C[C@@H]1O GAKMQHDJQHZUTJ-ULHLPKEOSA-N 0.000 abstract 1
- 229960001048 fluorometholone Drugs 0.000 abstract 1
- FAOZLTXFLGPHNG-KNAQIMQKSA-N fluorometholone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@]2(F)[C@@H](O)C[C@]2(C)[C@@](O)(C(C)=O)CC[C@H]21 FAOZLTXFLGPHNG-KNAQIMQKSA-N 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
- 230000001530 keratinolytic effect Effects 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000006072 paste Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229960005205 prednisolone Drugs 0.000 abstract 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 229940029070 triacetyldithranol Drugs 0.000 abstract 1
- 150000005691 triesters Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH19868 | 1968-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL6900235A true NL6900235A (en, 2012) | 1969-07-10 |
Family
ID=4181484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL6900235A NL6900235A (en, 2012) | 1968-01-08 | 1969-01-07 |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE726574A (en, 2012) |
| DE (1) | DE1817288A1 (en, 2012) |
| FR (1) | FR2000053A1 (en, 2012) |
| GB (1) | GB1225830A (en, 2012) |
| IE (1) | IE33109B1 (en, 2012) |
| IL (1) | IL31289A (en, 2012) |
| NL (1) | NL6900235A (en, 2012) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2565966B1 (fr) * | 1984-06-13 | 1986-08-29 | Cird | Aryl-10 dihydroxy-1,8 anthrones et leurs esters, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
| ATE262952T1 (de) * | 2000-11-14 | 2004-04-15 | Eugen Georg Dr Med Den Benkert | Topical-antipsoriaticum mit harnstoff, einem corticoid und einem desinfektionsmittel |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1070949A (en) * | 1964-10-16 | 1967-06-07 | Hyman Yarrow | Topical compositions for the treatment of psoriasis |
-
1968
- 1968-12-18 IL IL31289A patent/IL31289A/en unknown
- 1968-12-28 DE DE19681817288 patent/DE1817288A1/de active Pending
- 1968-12-31 GB GB1225830D patent/GB1225830A/en not_active Expired
-
1969
- 1969-01-02 IE IE9/69A patent/IE33109B1/xx unknown
- 1969-01-07 BE BE726574D patent/BE726574A/xx unknown
- 1969-01-07 FR FR6900084A patent/FR2000053A1/fr not_active Withdrawn
- 1969-01-07 NL NL6900235A patent/NL6900235A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE33109B1 (en) | 1974-03-20 |
| BE726574A (en, 2012) | 1969-07-07 |
| FR2000053A1 (fr) | 1969-08-29 |
| GB1225830A (en, 2012) | 1971-03-24 |
| IE33109L (en) | 1969-07-08 |
| IL31289A0 (en) | 1969-02-27 |
| DE1817288A1 (de) | 1969-08-07 |
| IL31289A (en) | 1974-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO164905C (no) | Fremgangsmaate for fremstilling av 16,17-acetal-pregnanderivater. | |
| GB1047518A (en) | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds | |
| US3073743A (en) | Antiinflammatory steroid acetonide compositions and therapy | |
| US4910192A (en) | Topically active steroidal anti-inflammatory agents | |
| US2736681A (en) | Chemical compounds | |
| GB1472308A (en) | Steroidal topical cream base | |
| IE39738L (en) | Triamcinolone derivative | |
| US4576936A (en) | 6α-Fluoro-9α-chloro-prednisolone 17,21-diesters | |
| US3984544A (en) | Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor | |
| GB1225830A (en, 2012) | ||
| IE41287L (en) | Steroid pharmaceutical composition | |
| US3694471A (en) | 17-valerate ester of 6{60 ,9{60 -difluorohydrocortisone, its compositions and use as an anti-inflammatory agent | |
| GB1328998A (en) | Process of corticosteroids | |
| GB1232745A (en, 2012) | ||
| GB1187395A (en) | Terpenic, Homoterpenic and Terpenylacetic Acid Esters ofSteroid 21-ols | |
| GB924931A (en, 2012) | ||
| GB1511820A (en) | 16-methyl-9alpha-halo steroid ethers and esters and their preparation | |
| GB963938A (en) | New steroid esters | |
| GB2018257A (en) | 11 beta -Silylation in corticoid synthesis | |
| US3857941A (en) | Pharmaceutical compositions and use of prednisolone 17-benzoate | |
| GB1430223A (en) | Anti-inflammatory composition comprising steroids | |
| GB1223087A (en) | Improvements in or relating to new steroid 21-esters, method for their preparation and therapeutic composition containing same | |
| GB1028745A (en) | Pharmaceutical preparations containing corticosteroids | |
| GB1395820A (en) | Preparation of 21-inorganic esters of corticosteroids and salts thereof | |
| US4323564A (en) | Esters of 6-chloro-11β, 17α,21-trihydroxypregna-1,4,6-triene-3,20-dione |